Patient Centric Development: Exploring Oral Obesity Therapeutics to Move Away from Injectable Peptides
Time: 4:50 pm
day: Conference Day One
Details:
- Explore enabling the development of oral obesity therapeutics that achieve bioavailability and efficacy comparable to injectable peptides
- Analyze the underlying mechanisms by which oral therapeutics modulate metabolic pathways and appetite suppression to induce weight loss, highlighting recent innovations in drug delivery systems
- Explore data comparing the efficacy, safety, and patient adherence of oral obesity therapeutics versus traditional injectable treatments, emphasizing the potential for improved patient outcomes
